Clinical Lymphoma, Myeloma and Leukemia
Công bố khoa học tiêu biểu
* Dữ liệu chỉ mang tính chất tham khảo
Sắp xếp:
Risk of Infection Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Clinical Lymphoma, Myeloma and Leukemia - Tập 20 - Trang 87-97.e5 - 2020
Daunorubicin 90 mg/m 2 in Acute Myeloid Leukemia Induction: Increased Toxicity in Young Patients
Clinical Lymphoma, Myeloma and Leukemia - Tập 17 - Trang 527-531 - 2017
Clinical Outcomes With Ring Sideroblasts and SF3B1 Mutations in Myelodysplastic Syndromes: MDS Clinical Research Consortium Analysis
Clinical Lymphoma, Myeloma and Leukemia - Tập 18 - Trang 528-532 - 2018
Treatment of Older Patients With Newly Diagnosed AML Unfit for Traditional Therapy
Clinical Lymphoma, Myeloma and Leukemia - Tập 18 - Trang 553-557 - 2018
R-CHOP or R-HyperCVAD With or Without Autologous Stem Cell Transplantation for Older Patients With Mantle Cell Lymphoma
Clinical Lymphoma, Myeloma and Leukemia - Tập 15 - Trang 92-97 - 2015
SOHO State of the Art Updates and Next Questions | Beyond BCL-2 Inhibition in Acute Myeloid Leukemia: Other Approaches to Leverage the Apoptotic Pathway
Clinical Lymphoma, Myeloma and Leukemia - Tập 22 - Trang 652-658 - 2022
The Importance of IGHV Mutational Status in del(11q) and del(17p) Chronic Lymphocytic Leukemia
Clinical Lymphoma, Myeloma and Leukemia - Tập 12 - Trang 132-137 - 2012
Standardizing Clinical Workflow for Assessing Minimal Residual Disease by Flow Cytometry in Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia - Tập 23 - Trang e41-e50 - 2023
AML-399 Real-World Outcomes of Decitabine + Venetoclax With IDH Inhibition for AML
Clinical Lymphoma, Myeloma and Leukemia - Tập 23 - Trang S297 - 2023
NP-109: Improving long-term quality of life for patients living with multiple myeloma: a service evaluation
Clinical Lymphoma, Myeloma and Leukemia - Tập 21 - Trang S169 - 2021
Tổng số: 2,037
- 1
- 2
- 3
- 4
- 5
- 6
- 204